More Europa webinar, with the participation of Raphaël Porcher: “How can real world registry data be used to augment clinical trial data to improve drug development and regulatory decision making”

Mark your calendars for our next training session on 13 February — “How can real world registry data be used to augment clinical trial data to improve drug development and regulatory decision making”

You are invited to be part of the More-EUROPA training on “How can real world registry data be used to augment clinical trial data to improve drug development and regulatory decision making”. The More-EUROPA project is working towards a more efficient use of real-world data in the development, registration, and assessment of medicinal products in Europe. It focuses on the value and use of registry-based real-world data in augmenting clinical trial data in the regulatory and health technology assessment decision-making process.

In this webinar session, you’ll have the opportunity to learn more about:

• How registry data can be used for early development decision making
• How real-world evidence has contributed to regulatory decision making in marketing authorisation applications at the EMA
• Patients’ perspectives on real-world data

Secure your spot: Sign Up Here